InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 16.00
+0.10 (0.63%)
Feb 11, 2026, 2:59 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.72 billion as of February 13, 2026. Its market cap has decreased by -1.85% in one year.
Market Cap
1.72B
Enterprise Value
1.50B
Revenue
55.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.00
Market Cap Chart
Since September 13, 2012, InnoPharmax's market cap has increased from 1.54B to 1.72B, an increase of 11.64%. That is a compound annual growth rate of 0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.72B | -4.76% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Golden Biotechnology | 2.71B |
| Johnson Chemical Pharmaceutical Works | 2.55B |
| LIWANLI Innovation | 2.49B |
| Allied Biotech | 2.35B |
| TSH Biopharm Corporation | 2.15B |
| GeneFerm Biotechnology | 1.81B |
| Tien Liang BioTech | 1.76B |
| Winston Medical Supply | 1.50B |